Information de reference pour ce titreAccession Number: | 01451458-201903010-00004.
|
Author: | Bremmer, Derek N; Moffa, Matthew A; Ma, Kiet; Bean, Holly R; Snatchko, Joseph; Trienski, Tamara L; Watson, Courtney; Walsh, Thomas L
|
Institution: | Department of Pharmacy, Allegheny General Hospital, Allegheny Health Network Division of Infectious Diseases, Allegheny General Hospital, Allegheny Health Network Division of Infectious Diseases, Western Pennsylvania Hospital, Allegheny Health Network Division of Pulmonary Medicine, Allegheny General Hospital, Allegheny Health Network, Pittsburgh, Pennsylvania Department of Medicine, Allegheny General Hospital, Allegheny Health Network, Pittsburgh, Pennsylvania Center for Inclusion Health, Allegheny General Hospital, Allegheny Health Network, Pittsburgh, Pennsylvania
|
Title: | |
Source: | Clinical Infectious Diseases. 68(5):725-730, March 01, 2019.
|
Author Keywords: | procalcitonin; chronic obstructive pulmonary disease; COPD; antibiotics; azithromycin.
|
References: | 1. Mannino DM, Kiriz VA. Changing the burden of COPD mortality. Int J Chron Obstruct Pulmon Dis2006; 1:219-33.
2. Wier LM, Elixhauser A, Pfuntner A, Au DH. Overview of hospitalizations among patients with COPD, 2008: statistical brief #106. Healthcare Cost and Utilization Project (HCUP) statistical briefs. Rockville, MD: Agency for Healthcare Research and Quality, 2006.
3. Lieberman D, Lieberman D, Gelfer Y, et al Pneumonic vs nonpneumonic acute exacerbations of COPD. Chest2002; 122:1264-70.
4. Vogelmeier CF, Criner GJ, Martinez FJ, et al Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med2017; 195:557-82.
5. Lopez-Campos JL, Hartl S, Pozo-Rodriguez F, Roberts CM; European COPD Audit Team. Antibiotic prescription for COPD exacerbations admitted to hospital: European COPD audit. PLoS One2015; 10:e0124374.
6. Woodhead M, Blasi F, Ewig S, et al Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections-full version. Clin Microbiol Infect2011; 17(Suppl 6):E1-59.
7. Schuetz P, Christ-Crain M, Thomann R, et al ProHOSP Study Group. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA2009; 302:1059-66.
8. Muller B, White JC, Nylen ES, Snider RH, Becker KL, Habener JF. Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab2001; 86:396-404.
9. Christ-Crain M, Muller B. Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators. Eur Respir J2007; 30:556-73.
10. Linscheid P, Seboek D, Zulewski H, Keller U, Muller B. Autocrine/paracrine role of inflammation-mediated calcitonin gene-related peptide and adrenomedullin expression in human adipose tissue. Endocrinology2005; 146:2699-708.
11. Mathioudakis AG, Chatzimavridou-Grigoriadou V, Corlateanu A, Vestbo J. Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis. Eur Respir Rev2017; 26. doi:10.1183/16000617.0073-2016.
12. Bremmer DN, DiSilvio BE, Hammer C, et al Impact of procalcitonin guidance on management of adults hospitalized with chronic obstructive pulmonary disease exacerbations. J Gen Intern Med2018; 33:692-7.
13. Stolz D, Christ-Crain M, Bingisser R, et al Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest2007; 131:9-19.
14. Verduri A, Luppi F, D'Amico R, et al Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trial. PLoS One2015; 10:e0118241.
15. Walsh TL, DiSilvio BE, Hammer C, et al Impact of procalcitonin guidance with an educational program on management of adults hospitalized with pneumonia. Am J Med2018; 131:201.e1-8.
16. bioMerieux. VIDAS BRAHMS. Procalcitonin technical details. Available at: http://www.biomerieux-diagnostic...- ouverture dans une nouvelle fenêtre. Accessed 14 December 2017.
17. Albert RK, Connett J, Bailey WC, et al COPD Clinical Research Network. Azithromycin for prevention of exacerbations of COPD. N Engl J Med2011; 365:689-98.
18. Boucher HW, Talbot GH, Bradley JS, et al Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis2009; 48:1-12.
|
Language: | English.
|
Document Type: | Articles and Commentaries.
|
Journal Subset: | Clinical Medicine. Life & Biomedical Sciences.
|
ISSN: | 1058-4838
|
DOI Number: | https://dx.doi.org/10.1093/cid/c...- ouverture dans une nouvelle fenêtre
|
Annotation(s) | |
|
|